Figure 6.
For myxinidin HPA sensorgrams in DOPE/DOPG/CL (65/23/12% mol) (A), in DOPE/DOPG (80/20% mol) (C) liposomes and L1 sensorgram in DOPE/DOPG/CL (65/23/12% mol) liposomes (E) at different peptide concentrations; for WMR, HPA sensorgrams in DOPE/DOPG/CL (65/23/12% mol) (B), in DOPE/DOPG (80/20% mol) (D) liposomes and L1 sensorgram in DOPE/DOPG/CL (65/23/12% mol) (F) liposomes at different peptide concentrations.